Up Next
Back to Show
PBS NewsHour
Did outcry on social media lead to Mylan’s generic EpiPen?
After news broke that the price of EpiPen injectors has skyrocketed, the allergy medicine’s maker, Mylan, announced its intention to offer a generic version of the product, to be sold at half the market price of the original. The New York Times’ Andrew Pollack and the University of Minnesota's Stephen Schondelmeyer talk with Gwen Ifill about the role public outcry played in the company's decision.
Support Provided By
Season
57:46
April 18, 2024 - PBS NewsHour full episode
56:45
April 17, 2024 - PBS NewsHour full episode
56:44
The Supreme Court considers whether a charge of obstructing an official proceeding can be used to prosecute Capitol rioters and Donald Trump.
57:46
April 15, 2024 - PBS NewsHour full episode
26:44
Israel considers how to respond to Iran’s attack as the U.S. and other world leaders scramble to contain the confrontation.
26:45
Israel is on high alert as the nation awaits an attack from Iran.
57:46
Israel prepares for a possible attack from Iran in retaliation for Israel's strike on Iran's consulate in Damascus.
56:45
The White House announces the largest expansion of background checks for gun purchases in decades.
57:46
Is inflation under control enough for the Fed to lower interest rates? "PBS NewsHour" speaks with a key player watching the economy.
56:24
Arizona's Supreme Court upholds a Civil War-era abortion law, effectively banning the procedure in the state.
56:45
Israeli forces withdraw from southern Gaza and cease-fire talks resume in Cairo six months after Hamas’ Oct. 7 attack.
26:45
As the NCAA women’s basketball tournament wraps up, why women’s sports are reaching new heights in popularity and revenue.